Search Results - "Saad‐Hossne, R."

Factors affecting the incidence of early endoscopic recurrence after ileocolonic resection for Crohn's disease: a multicentre observational study by Barcelos, I. F., Kotze, P. G., Spinelli, A., Suzuki, Y., Teixeira, F. V., Albuquerque, I. C., Saad‐Hossne, R., da Silva Kotze, L. M., Yamamoto, T.

“…Aim Early endoscopic recurrence is frequently observed in patients following resection for Crohn's disease (CD). However, factors affecting the incidence of an…”
Get full text

Fecal microbiota transplantation in refractory ulcerative colitis – a case report by Moutinho, B. D., Baima, J. P., Rigo, F. F., Saad-Hossne, R., Rodrigues, J., Romeiro, F. G., Sassaki, L. Y.

“…Studies comparing gut microbiota profiles of inflammatory bowel disease (IBD) patients have shown several changes in microbiota composition, with marked…”
Get full text

Letter: pathogenesis of tumour necrosis factor-alpha antagonists-induced psoriasiform lesions by Denadai, R., Teixeira, F. V., Saad-Hossne, R.

Get full text

M061 ACETYLSALICYLIC ACID-INDUCED COMPLETE DESTRUCTION OF PERITONEAL ENDOMETRIOSIS – AN EXPERIMENTAL STUDY IN RABBITS by Saad-Hossne, R, Barreto, A.B, Denadai, R

Get full text

Inflammatory Bowel Disease Epidemiology in São Paulo State, Brazil [Corrigendum] by Galhardi Gasparini, Rodrigo, Sassaki, Lígia Yukie, Saad-Hossne, Rogerio

“…Gasparini RG, Sassaki LY, Saad-Hossne R. Clin ExpGastroenterol. 2018;11:423-429.The authors have advised there is an error in Figure 1 onpage 425. The age…”
Get full text

Opinion of Hepatic Transplant Waiting List Patients Regarding Split Liver Transplantation by Petribu de Faria, E, Llanos, J.C, Neto, A.B, Silva, A.P.C, Winckler, C.C, Mutti, A, Saad-Hossne, R, Silva, G.F, Gomes, M.R.B, Callile de Paula, R.C, Biagioni, D.S, Almeida, R.A.M.B, Rosa, R.A.G, Guadagnucci, J.C

“…Abstract Background Split liver transplantation (SLT) increases organ supply for hepatic transplantation. Long-term patient survival and complication rates…”
Get full text

PUBLICATIONS IN INFLAMMATORY BOWEL DISEASES IN THE ARCHIVES OF GASTROENTEROLOGY by Saad-Hossne, Rogerio

Get full text

N02 The importance of the multidisciplinary team (MDT) and its impact on quality of life and medication adherence in patients with Inflammatory Bowel Disease by Herrerias, G, Barros, J R, Lopes, M A, Saad-Hossne, R, Baima, J P, Sassaki, L Y

Get full text

PGI5 LONG TERM ECONOMIC VALUE OF TIGHT CONTROL WITH ADALIMUMAB-BASED TREATMENT IN CROHN'S DISEASE: THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE by Saad-Hossne, R., dos Santos, R., Moreira, R.P., Lee, W.J., Chaves, L.

Get full text

N17 Profile of ostomy patients treated at a referral hospital for inflammatory bowel disease by Barros, J, Herrerias, G, Oliveira, L, Baima, J, Alencar, R, Saad-Hossne, R, Sassaki, L

“…Abstract Background As part of the surgical treatment of inflammatory bowel disease (IBD), sometimes is necessary the intestinal stoma. The aim of this study…”
Get full text

P470 Real-world characteristics and complications of patients with Ulcerative Colitis receiving conventional therapy in the public healthcare system in Brazil by Galhardi Gasparini, R, Yukie Sassaki, L, Lima Martins, A, Saad Hossne, R, Watanabe de Oliveira, R, Yang Santos, C, Biatti Barreto, T

Get full text

P1108 Factors Associated with Delayed Diagnosis of Inflammatory Bowel Disease and Risk of Complications: Analysis of the Brazilian National Registry by Ribas Andrade, A, Froes, R, Sassaki, L, Faria, M, Parente, J M, Bezerra, G, Pertence, P, Kaiser Junior, R, Zabot, G, Feldmann, J, Santos, C H, Chiquetti, C, Almeida, N, Fortes, F, Maia, A, Parra, R, Santana, G, Lopes, M C, Salgado, V, Carvalho, B, Bafutto, M, Araújo, S, Souza, H, Maximiano, F L, Nascimento, C, Saad-Hossne, R, Flores, C

Get full text

N14 Professional profile of nurses working with inflammatory bowel disease in Brazil by Barros, J, de Aguiar Alencar, R, Saad-Hossne, R, Yukie Sassaki, L

“…Abstract Background This study aimed to identify the profile of nurses working with inflammatory bowel disease (IBD) in Brazil and to characterise the…”
Get full text

Inflammatory bowel disease epidemiology in São Paulo State, Brazil by Gasparini, Rodrigo Galhardi, Sassaki, Ligia Yukie, Saad-Hossne, Rogerio

“…This study aimed to estimate the incidence and prevalence of inflammatory bowel disease (IBD) in São Paulo, Brazil, for 2012-2015. This observational,…”
Get full text

P162 Earlier (luminal) surgery is associated to reduced postoperative morbidity in ileocaecal Crohn’s disease: results from SURGICROHN – LATAM study by IBD Latam Consortium, S, Avellaneda, N L, Saddy Rodrigues Coy, C, Sarubbi Fillmann, H, Saad-Hossne, R, Muñoz, J P, García-Duperly, R, Bellolio, F, Rotholtz, N, Rossi, G, Marquez V, J R, Cillo, M, Lacerda-Filho, A, Carrie, A, Yuki Maruyama, B, Sarubbi Fillmann, L, Ferro, E, Londoño-Schimmer, E, Iglesias, A, Bras Harriott, C, Campana, J P, Londoño Estrada, D, Kotze, P G

Get full text

Vedolizumab Safety During Pregnancy and Lactation in a Patient with Ulcerative Colitis: A Case Report by Pinto, Fernanda Patrícia Jeronymo, Dutra, Renata de Medeiros, Almeida, Livia Cafundo, Craveiro, Marcela Maria Silvino, Baima, Julio Pinheiro, Saad-Hossne, Rogerio, Sassaki, Ligia Yukie

“…Inflammatory bowel disease (IBD) affects young adults of reproductive age, and questions related to pregnancy and breastfeeding are common in clinical…”
Get full text

N015 Perception of IBD patients about sexuality by Barros, J R, de Aguiar Alencar, R, Baima, J P, Saad-Hossne, R, Sassaki, L Y

“…Abstract Background inflammatory bowel disease (IBD) can cause a great impact on the patient’s life causing implications for functional capacity, social and…”
Get full text

P653 Efficacy and safety of an additional 8 weeks of tofacitinib induction therapy: Updated results of the OCTAVE Open study for tofacitinib 8-week induction non-responders by Rubin, D T, Dubinsky, M C, Danese, S, Saad-Hossne, R, Ponce de Leon, D, Maller, E, Lawendy, N, Kwok, K, Su, C

“…Abstract Background Tofacitinib is an oral, small-molecule JAK inhibitor for the treatment of ulcerative colitis (UC). Efficacy and safety of tofacitinib were…”
Get full text

P831 Clinical factors associated with severity in patients with Inflammatory Bowel Disease in Brazil (On Behalf of GEDIIB) by Froes, R, Andrade, A R, Faria, M A G, Parra, R S, Zaltman, C, Souza, H S P, Santos, C H M D S, Bafutto, M, Quaresma, A B, Santana, G O, Rafael Luís Luporini, R L, Lima Junior, S F D, Miszputen, S J, Souza, M M D, Herrerias, G S P, Kaiser Junior, R L, Nascimento, C R D, Féres, O, Barros, J R D, Guimarães, C D S, Sassaki, L Y, Saad-Hossne, R

Get full text

P265 Evaluation of the quality-of-care parameters in patients with inflammatory bowel disease in Brazilian hospitals by Vilela Vilela, E, Serafim Parra, R, Yukie Sassaki, L, da Costa Ferreira, S, Araújo Lisboa, R, Oliveira Santana, G, Luiz Parente, J M, Cassol, O, Gustavo Kotze, P, Pereira Westphalen, A, Zaltman, C, Marques dos Santos, C H, Hamer Sousa Clara, A P, Lovatti, R, de Assis Gonçalves Filho, F, Vieira, A, Filardi Simiqueli Durante, R, Bafutto, M, Botelho Quaresma, A, de Freitas Lins Neto, M Á, Barrio Bortoli, Z, Coelho Ludvig, J, Machado de Souza, M, Freire, C, Martinelli, V, Antunes de Brito, C A, Pandolfo Zabot, G, Medeiros Soares Celani, L, Mônica de Oliveira Leite, S, Saad Hossne, R

Get full text